Posted February 7, 2008
Salix Names BioDelivery Sciences International CEO to Board
Post a comment
Print this storyE-mail story
Share
Raleigh, N.C. —
Mark Sirgo, chief executive officer at BioDelivery Sciences International (Nasdaq: BDSI), is joining the board of directors at Salix Pharmaceuticals (Nasdaq: SLXP).
Sirgo is a graduate of Ohio State University with a degree in pharmacy. He earned a doctorate at the Philadelphia College of Pharmacy and Science. He has more than 25 years of experience in the pharmaceutical industry.
BDSI, which is based in the Triangle, is developing breakthrough pain treatments.
Salix, which is based in Raleigh, develops and sells a variety of gastrointestinal diseases.
Featured
Hot Off The Wire
- Red Hat's new Fedora lead; Cree LED breakthrough; Google, Cisco top 'green' list; Oracle rejects SAP settlement; Yahoo board shakeup
- Will Cisco report progress in its turnaround efforts?
- Cisco server fire threat; Lenovo Android upgrade; cloud startup vs. Cisco; Epic's Blesinski to host awards; Google 'Solve for X'
E-mail Preferences
